Feature Channels: Vaccines

• share
• favorite_border

妙佑医疗国际的数据科学家曾制作高精度计算机模型，用于预测美国COVID-19病例的趋势。目前，他们又开展了一项新的研究，研究结果表明，提高疫苗接种率对于减少病例和控制疫情至关重要。

• share
• favorite_border

Los científicos de datos de Mayo Clinic que desarrollaron un modelado computarizado de gran precisión para predecir las tendencias de los casos de COVID-19 en Estados Unidos cuentan con una investigación nueva que muestra la importancia de una tasa alta de vacunación para reducir la cantidad de casos y controlar la pandemia.

• share
• favorite_border

Giving birth is stressful enough. Adding a pandemic to the mix has only increased anxiety among today’s moms-to-be.

• share
• favorite_border

Every year the World Health Organization recognizes the last week of April as World Immunization Week – a time to celebrate the millions of lives saved and the eradication of multiple diseases because of vaccines. However, access to vaccines is still a barrier for many children in our community, so public health experts with The University of Texas Health Science Center at Houston (UTHealth) are hitting the ground to bring lifesaving immunizations directly to them.

• share
• favorite_border

Individuals who self-identify as Republicans became more skeptical of a potential COVID-19 vaccine and other inoculations, such as the flu shot, over the course of the pandemic, reveals a new study by the University of California San Diego’s Rady School of Management.

• share
• favorite_border

• share
• favorite_border

• share
• favorite_border

Researchers Identify Troubling Disparities Along Race, Income, Education Lines

• share
• favorite_border

Just 16% of men 18 to 21 years old have received at least one dose of the HPV vaccine at any age. Yet oropharyngeal cancer, which occurs in the throat, tonsils, and back of the tongue, is now the leading cancer caused by HPV — and 80% of those diagnosed with it are men.

• share
• favorite_border

The AstraZeneca COVID-19 vaccine is suspected of being linked to a small number of deep vein thrombosis cases, which led several countries in Europe to suspend AstraZeneca injections. Researchers explored a hypothesis that this pause, even if short, could cause additional deaths from the faster spread of COVID-19. In Chaos, they report using an epidemiological model and statistical analysis to estimate excess deaths resulting from suspending AstraZeneca vaccinations and those potentially linked to DVT-adverse events in France and Italy.

• share
• favorite_border

The work performed by dozens of scientists at Pfizer, BioNTech, Texas Biomed, the SNPRC and scientific partners around the world from April to July of 2020 is now published in the scientific journal Nature. In the paper titled “Immunogenic BNT162b vaccines protect rhesus macaques from SARS-CoV-2” published on Feb. 1, 2021, scientists noted that the vaccine candidate tested for Pfizer “protected the lower respiratory tract from the presence of viral RNA and with no evidence of disease enhancement.”

• share
• favorite_border

COVID-19 vaccination has become a lightning rod for controversy over “vaccine passports” and claims of violations of medical privacy or individual rights. But as two experts explain, there's a long history of efforts to protect the health of others by requiring individuals to provide proof of vaccination or of a past infection, or seek a medical or religious exception.

• share
• favorite_border

• share
• favorite_border

A small study from Mayo Clinic researchers raises the concern that some transplant patients may have a limited immune response after being vaccinated for COVID-19 with an mRNA vaccine. Their findings are published as a letter to the editor in the American Journal of Transplantation.

• share
• favorite_border

Researchers from the University of Oxford and their partners have today reported findings from a Phase IIb trial of a candidate malaria vaccine, R21/Matrix-M, which demonstrated high-level efficacy of 77% over 12-months of follow-up.

• share
• favorite_border

Over the last year, parents have been doing their part to stay indoors and social distance to help stop the spread of COVID-19. But staying home has led to many children missing their annual check-ups and recommended vaccinations.

• share
• favorite_border

Newly published analyses of data from polls of teens and young adults show the importance of framing pandemic-related messaging in terms of their role in protecting others from COVID-19.

• share
• favorite_border

A 7-year-old patient at Rush University Children’s Hospital named Kashton has been helping get band-aids for the vaccine clinic ready, alongside one of his nurses. Together, they’ve opened hundreds.

• share
• favorite_border

Requirement would go into effect for the fall 2021 term contingent upon one or more vaccines receiving full approval

• share
• favorite_border

A synthetic DNA vaccine candidate for Middle East respiratory syndrome coronavirus (MERS-CoV) developed at The Wistar Institute induced potent immune responses and afforded protective efficacy in non-human primate (NHP) models when given intradermally in abbreviated, low-dose immunization regimen.

• share
• favorite_border

The Johns Hopkins Malaria Research Institute at the Johns Hopkins Bloomberg School of Public Health will host its annual World Malaria Day Symposium this Friday, April 23, from 9 a.m. to 5:30 p.m. EDT.

• share
• favorite_border

Student members of the Texas Tech University Health Sciences Center (TTUHSC) Latino Medical Student Association (LMSA) answered questions and myths about the COVID-19 vaccine for the Hispanic community.

• share
• favorite_border

NEWS STORIES IN THIS ISSUE: PREGNANT AFTER THE FIRST DOSE OF COVID-19 VACCINE — NOW WHAT? STUDY SHOWS VACCINES MAY PROTECT AGAINST NEW COVID-19 STRAINS … AND MAYBE THE COMMON COLD EXPANDED DASHBOARD TOOL RANKS ACCESSIBILITY OF STATE VACCINE WEBSITES

• share
• favorite_border

Clinical trials have begun on a new vaccine candidate that may protect against variants of the SARS-CoV-2 virus. Protein structures determined at the Advanced Photon Source helped to guide the development of this vaccine.

• share
• favorite_border

Iowa State’s COVID-19 vaccination plan ramps up starting April 20 as all adult students qualify and a mass vaccination clinic takes over State Gym’s three basketball courts. But it’s not as simple as setting up booths and having vaccines ready. That’s where industrial engineering students come in.

• share
• favorite_border

Irvine, Calif., April 20, 2021 — Taking what it has learned from remote work and learning practices over the past 15 months, the University of California, Irvine will begin instituting back-to-campus plans for employees and students that will include hybrid workplaces and flexible coursework. The transition back to campus will be managed in phases starting July 1, with the university being fully operational in person by Sept.

• share
• favorite_border

A new study at Tel Aviv University found that the British variant (termed: B.1.1.7) of Covid-19 is 45% more contagious than the original virus.

• share
• favorite_border

A coalition of 60 top hospitals and health care institutions have joined forces in a nationwide campaign to encourage adults to get vaccinated against COVID-19. Led by Cleveland Clinic and Mayo Clinic, the campaign "Get the Vaccine to Save Lives" is designed to reassure the public that vaccines are safe, effective and necessary to achieve herd immunity and return to normal activities.

• share
• favorite_border

Stanley H. Weiss, an epidemiologist in infectious and chronic diseases, and a professor at the Rutgers New Jersey Medical School and the Rutgers School of Public Health, talks about vaccine side effects, the hesitancy that still exists and why it is important to get vaccinated when it’s your turn.

• share
• favorite_border

Two new studies published in Blood suggest that the mRNA COVID-19 vaccine may have reduced efficacy in individuals with chronic lymphocytic leukemia (CLL) and multiple myeloma, two types of blood cancer.

• share
• favorite_border

• share
• favorite_border

Leading healthcare and faith leaders addressed key issues that are contributing to vaccine hesitancy in Black communities during a national online discussion this week, explaining that a lack of access to healthcare, concerns over vaccine safety, and religious beliefs are keeping many from getting COVID-19 vaccines.

• share
• favorite_border

New findings from Penn suggest that people who have recovered from COVID-19 may only need a single mRNA vaccine dose. However, those who did not have COVID-19 did not have a full immune response until after a second vaccine dose, reinforcing the importance of completing the two recommended doses.

• share
• favorite_border

Elderly patients of female physicians are more likely than those of male physicians in the same outpatient practice to be vaccinated against the flu. This trend holds for all racial and ethnic groups studied and could provide insight into improving vaccination rates for influenza, COVID-19 and other illnesses

• share
• favorite_border

A large national clinical trial to evaluate the Pfizer-BioNTech COVID-19 vaccine for safety and efficacy in pregnant women is now open for enrollment at The University of Texas Health Science Center at Houston (UTHealth).

• share
• favorite_border

A new computational study suggests that a protein present in SARS-CoV-2, the virus that causes COVID-19, could be a target for future vaccines. The study is published ahead of print in the American Journal of Physiology-Lung Cellular and Molecular Physiology.

• share
• favorite_border

• share
• favorite_border

Radames and Ana Arocho were all smiles when they arrived on the white school bus, and their enthusiasm was contagious.

• share
• favorite_border

As older teens and young adults become eligible for COVID-19 vaccination across the country, and younger teens await their turn, new survey data suggest a strong readiness that has grown since fall. But just as with older generations, a shrinking but still sizable minority of people age 14 to 24 say they’re not willing to get vaccinated, or that their decision will depend on safety.

• share
• favorite_border

A slightly lighthearted guide to post-vaccination life, including how to help others who haven't gotten vaccinated yet.

• share
• favorite_border

Narratives are a powerful tool that can help explain complex issues, but they can also serve as sources of misinformation, which presents a challenge as public health agencies work to educate people about COVID-19 vaccine.

• share
• favorite_border

• share
• favorite_border

What can vaccine proponents, clinicians and public health communicators learn from “anti-vaxxers?” A lot, according to new guidance for pro-vaccination social media events written by University of Pittsburgh health scientists.

• share
• favorite_border

Nationwide, the rollout for the COVID-19 vaccine has been inequitable, with white individuals being vaccinated at higher rates compared to Black individuals.

• share
• favorite_border

• share
• favorite_border

A personalized cancer vaccine developed with the help of a Mount Sinai computational platform raised no safety concerns and showed potential benefit in patients with different cancers, including lung and bladder, that have a high risk of recurrence, according to results from an investigator-initiated phase I clinical trial presented during the virtual American Association for Cancer Research (AACR) Annual Meeting 2021, held April 10-15.

• share
• favorite_border

New research has for the first time compared images of the protein spikes that develop on the surface of cells exposed to the Oxford-AstraZeneca vaccine to the protein spike of the SARS-CoV-19 coronavirus.

• share
• favorite_border

• share
• favorite_border

Researchers at Michigan Medicine are helping lead the first national study of how highly allergic people react to mRNA COVID-19 vaccines. The trial, co-led by a U-M immunologist, will cover over 3,000 participants receiving the Pfizer and Moderna vaccines at up to 35 academic allergy research centers across the United States.